This page includes the latest FDA filings for Mirum Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | MIRM | DUNS 116902386 |
Device Company | Device | Date |
|---|---|---|
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2025-05-09 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2025-04-26 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2025-04-06 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2024-11-22 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2024-10-03 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2024-04-04 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2023-03-29 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2022-04-14 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2021-10-09 |
| Mirum Pharmaceuticals Inc. | Prescription Medication | 2021-10-02 |
| Mirum Pharmaceuticals Inc. | Livmarli | 2021-09-29 |
| SEC | 0001759425 | Mirum Pharmaceuticals, Inc. of DELAWARE |